来自MSN4 个月
Kisqali wins FDA nod for breast cancer treatment: Dosage, effectiveness and side effects of ...
Breast cancer claims around 6,70,000 lives in a year. As per the data released by the World Health Organisation (WHO) breast cancer was the most common cancer in women in 157 countries out of 185 ...
SurvivorNet on MSN4 个月
Major New Drug Approval For Preventing Recurrence In Early Stage Breast Cancer Patients ...
In a long awaited approveall, The Food and Drug Administration (FDA) has just approved the drug Kisqali (ribociclib) in ...